📄 Material News · CPHL Citi Pharma Ltd. has announced the board's approval and recommendation for a Scheme of Arrangement and Demerger involving the transfer of certain properties to a wholly-owned subsidiary, Citi Core Holdings (Private) Limited.
- The board meeting took place on 08 July 2026.
- The Scheme involves transferring two properties: 4.1 kanal in Gulberg III, Lahore, and 27.15 kanal in Mouza Haloki, Lahore.
- In exchange, Citi Core Holdings will issue 331,720,000 ordinary shares of PKR 10 each to Citi Pharma.
- The proposal is subject to shareholder approval and the sanction of the Lahore High Court.
- An Extraordinary General Meeting is scheduled for 08 July 2026 to discuss the Scheme.
About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange. A summary for information, not investment advice — the original filing is the authoritative record.
Original filing (PDF)